Non-viable keratinocyte cell composition or lysate for promoting wound healing
AssigneeN. V. Innogenetics S.A.
InventorHans Van Bossuyt
Life of this patent
Estimating the term…
Loading patent…
AssigneeN. V. Innogenetics S.A.
InventorHans Van Bossuyt
Estimating the term…
Cultures of keratinocyte cells are provided which are free from nonautologous fibroblasts and organ extracts, and which have a high speed of cell amplification for a minimum seeding density. The cultures can be cryopreserved in a buffered isotonic medium containing serum and a cryoprotectant. The cultures are produced by a process that does not involve the use of a feeder layer and organ extracts. A culture medium which can be used contains Medium 199, serum, epidermal growth factor, cholera toxin and/or hydrocortisone, and optionally insulin. A substance for wound healing and for cosmetic applications is derived from cultured human keratinocytes. A non-viable total keratinocyte lysate for use in promoting wound healing is produced by growing keratinocyte cells on a support, detaching the cells from the support, and lysing the detached cells to obtain the lysate which may be frozen and lyophilized. The cells may be grown without using a support to produce the lysate, or to produce a non-viable keratinocyte cell culture lyophilisate or spray dried non-viable keratinocyte cell composition for use in healing wounds.
A non-viable total keratinocyte lysate obtained by a process consisting essentially of:
A non-viable total keratinocyte cell culture lyophilisate obtained by a process consisting essentially of:
A spray dried non-viable total keratinocyte cell composition obtained by a process consisting essentially of:
A pharmaceutical composition to promote the healing of a wound, wherein said composition comprises a spray dried non-viable total keratinocyte cell composition according to claimed a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.